Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status

scientific article

Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CANLET.2015.09.020
P932PMC publication ID4686130
P698PubMed publication ID26472630

P2093author name stringXiaoming Yang
Jihong Sun
Lumin Chen
P2860cites workResponse to Facciorusso et alQ87245018
Combining radiofrequency ablation and ethanol injection may achieve comparable long-term outcomes in larger hepatocellular carcinoma (3.1-4 cm) and in high-risk locationsQ87363408
Global cancer statisticsQ22241238
Optimal combination of antiangiogenic therapy for hepatocellular carcinomaQ26799458
Current and future treatments for hepatocellular carcinomaQ26801211
Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysisQ26864261
Current systemic treatment of hepatocellular carcinoma: A review of the literatureQ27026036
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaQ27860783
Dendritic cells and the control of immunityQ27860918
Sorafenib in advanced hepatocellular carcinomaQ27861075
Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1α/VEGFAQ28483727
Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomesQ28538311
Nanodrug-enhanced radiofrequency tumor ablation: effect of micellar or liposomal carrier on drug delivery and treatment efficacyQ28542027
Hepatocellular carcinomaQ29616359
Radiofrequency ablation of hepatocellular carcinoma: Current statusQ30478030
Combination therapy with sorafenib and radiofrequency ablation for hepatocellular carcinoma: a glimmer of light after the storm trial?Q87245014
Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.Q30512830
The combined effect of radiofrequency and ethanol ablation in the management of large hepatocellular carcinomaQ30783858
Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indicationsQ33373882
Principles of and Advances in Percutaneous AblationQ33805803
Radiofrequency heat-enhanced chemotherapy for breast cancer: towards interventional molecular image-guided chemotherapyQ34195652
Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinomaQ34207863
Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumorsQ34399657
Thermal ablation of tumours: biological mechanisms and advances in therapy.Q34406134
Intrabiliary RF heat-enhanced local chemotherapy of a cholangiocarcinoma cell line: monitoring with dual-modality imaging--preclinical studyQ34495478
Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injectionQ34503100
Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injectionQ34720013
Radiofrequency ablation-induced upregulation of hypoxia-inducible factor-1α can be suppressed with adjuvant bortezomib or liposomal chemotherapy.Q34725980
Combination therapy with local radiofrequency ablation and systemic vaccine enhances antitumor immunity and mediates local and distal tumor regressionQ34876404
Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinomaQ35010394
Interventional Radiological Treatment of Hepatocellular Carcinoma: An UpdateQ35675131
Multimodal treatment of hepatocellular carcinoma (HCC).Q35834098
Resection and liver transplantation for hepatocellular carcinoma.Q36140302
Combination radiofrequency (RF) ablation and IV liposomal heat shock protein suppression: Reduced tumor growth and increased animal endpoint survival in a small animal tumor modelQ36142890
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profilingQ36288956
Current status of multimodal & combination therapy for hepatocellular carcinomaQ36436294
Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinomaQ36975036
Combination of radiofrequency ablation and immunotherapy.Q36991803
Science to Practice: Can We Expand Focal Interventional Oncologic Ablation Treatments into an Effective Systemic Therapy?Q37006322
Immunotherapeutic approaches to hepatocellular carcinoma treatmentQ37140685
Adjuvant liposomal doxorubicin markedly affects radiofrequency ablation-induced effects on periablational microvasculatureQ37196965
TACE versus TAE as therapy for hepatocellular carcinomaQ37300023
The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review.Q37357774
Multimodal therapy for hepatocellular carcinoma: a complementary approach to liver transplantationQ37716429
Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablationQ37727030
Loco-regional treatment of hepatocellular carcinomaQ37766546
Is Percutaneous Ethanol Injection Therapy Still Effective for Hepatocellular Carcinoma in the Era of Radiofrequency Ablation?Q37811920
CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvementQ37975880
Doxil® — The first FDA-approved nano-drug: Lessons learnedQ38000876
Recent progress in understanding, diagnosing, and treating hepatocellular carcinomaQ38052472
Hyperthermia-induced drug targetingQ38071664
New agents on the horizon in hepatocellular carcinomaQ38074429
Small- and Medium-sized Hepatocellular Carcinomas: Monopolar Radiofrequency Ablation with a Multiple-Electrode Switching System—Mid-term ResultsQ38091417
Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysisQ38201145
Advanced nanovehicles for cancer management.Q38225024
Ablation of hepatocellular carcinomaQ38254702
Surgical resection and liver transplantation for hepatocellular carcinomaQ38447653
Radiofrequency ablation combined with percutaneous ethanol injection in patients with hepatocellular carcinomaQ38885580
Sorafenib inhibits liver cancer growth by decreasing mTOR, AKT, and PI3K expressionQ38898942
Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma.Q39131172
Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinomaQ39585554
Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.Q40484234
In situ tumor ablation creates an antigen source for the generation of antitumor immunityQ40550098
Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinomaQ41482382
Transarterial Chemoembolization in Combination with Local Therapies for Hepatocellular Carcinoma: A Meta-AnalysisQ41761634
Challenges in combining antiangiogenic therapy with transarterial chemoembolization for hepatocellular carcinoma.Q41851928
Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression‐free survival for patients with hepatocellular carcinomaQ42286093
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.Q43601180
Combined use of percutaneous ethanol injection and radiofrequency ablation for the effective treatment of hepatocelluar carcinoma.Q44143177
Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptideQ44521099
Enlargement of thermal ablation zone by the combination of ethanol injection and radiofrequency ablation in excised bovine liver.Q44725748
Efficacy of combination therapies of percutaneous or laparoscopic ethanol-lipiodol injection and radiofrequency ablation.Q45152961
Radiofrequency Ablation: Inflammatory Changes in the Periablative Zone Can Induce Global Organ Effects, including Liver RegenerationQ45874404
Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observationQ46591334
Radiofrequency Ablation of Liver Tumors in Combination with Local OK-432 Injection Prolongs Survival and Suppresses Distant Tumor Growth in the Rabbit Model with Intra- and Extrahepatic VX2 TumorsQ46614619
Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locationsQ46743936
Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinomaQ46981754
Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and sizeQ47335511
Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinomaQ50927490
Combined radiofrequency ablation and ethanol injection with a multipronged needle for the treatment of medium and large hepatocellular carcinomaQ51738380
Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factorsQ51906803
A Comparison of US-guided Percutaneous Radiofrequency Ablation of Medium-sized Hepatocellular Carcinoma with a Cluster Electrode or a Single Electrode with a Multiple Overlapping Ablation TechniqueQ53222822
Multikinase inhibitor sorafenib transiently promotes necrosis after radiofrequency ablation in rat liver but activates growth signals.Q53247066
Percutaneous radiofrequency ablation of small hepatocellular carcinoma invisible on both ultrasonography and unenhanced CT: a preliminary study of combined treatment with transarterial chemoembolisationQ53509282
Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trialQ56785995
Combination therapy of radiofrequency ablation and bevacizumab monitored with power Doppler ultrasound in a murine model of hepatocellular carcinomaQ57317511
In vivo immunological antitumor effect of OK-432-stimulated dendritic cell transfer after radiofrequency ablationQ64126380
Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected casesQ71620935
Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinomaQ72992727
Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinomaQ73074276
Percutaneous tumor ablation: increased coagulation by combining radio-frequency ablation and ethanol instillation in a rat breast tumor modelQ73282091
Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term resultsQ74067155
Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic featuresQ78439686
Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbitsQ79166964
Micrometastases of solitary hepatocellular carcinoma and appropriate resection marginQ79777704
Radiofrequency ablation: variability in heat sensitivity in tumors and tissuesQ80313163
Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in miceQ80642628
Systemic treatment of colorectal cancerQ81253030
Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort studyQ86000666
P433issue1
P407language of work or nameEnglishQ1860
P921main subjecthepatocellular carcinomaQ1148337
P304page(s)78-84
P577publication date2015-10-12
P1433published inCancer LettersQ326372
P1476titleRadiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status
P478volume370

Reverse relations

cites work (P2860)
Q49985544131I-Labeled Copper Sulfide-Loaded Microspheres to Treat Hepatic Tumors via Hepatic Artery Embolization.
Q92711036Adjuvant Treatment of Hepatocellular Carcinoma: Prospect of Immunotherapy
Q29248618Current applications and future prospects of nanomaterials in tumor therapy
Q52568926Effect of Microbubble-Enhanced Ultrasound on Radiofrequency Ablation of Rabbit Liver
Q50076590Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.
Q39274269Innovative Techniques for Image-Guided Ablation of Benign Thyroid Nodules: Combined Ethanol and Radiofrequency Ablation
Q26744830Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma
Q64084332Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram
Q38749532Radiofrequency hyperthermia-enhanced herpes simplex virus-thymidine kinase/ganciclovir direct intratumoral gene therapy of hepatocellular carcinoma
Q92841208Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma
Q39403724The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma

Search more.